RRE Ventures Acquisition

For investors tracking pre-IPO SPAC mechanics, this filing compresses the regulatory timeline but offers zero visibility into target selection, trust seeding amounts, or default redemption windows. The acceleration request signals that the underwriter and corporate legal team consider the prospectus draft sufficiently mature to trigger pricing logistics and bookbuilding. Until the Registration Statement actually declares effective and net proceeds are placed into a segregated trust, there are no actionable redemption dates, sponsor promote structures, or extension votes to evaluate.

This filing provides the full IPO prospectus for RRE Ventures Acquisition Corp. (RREV), a SPAC sponsored by RRE Ventures. Key items for investors: trust per share is $10.00, deadline to complete a business combination is 24 months from closing (with unlimited extensions subject to shareholder approval and redemption rights), and public shareholders will experience immediate and substantial dilution (up to 98.9% in a maximum redemption scenario). The filing also discloses significant conflicts of interest, including that management has fiduciary duties to other entities and may sponsor other SPACs. The document is essential for evaluating the IPO investment.

This is the definitive registration statement for a new $250 million SPAC with a 24-month deadline from closing (expected April 2028). It establishes the baseline trust value per share ($10.00, likely $10.06 with interest), redemption procedures (public shareholders can redeem at $10.00 per share plus interest, subject to a 15% aggregate cap on redemptions without consent), sponsor economics (founder shares at ~$0.003 per share, 4.51M private placement warrants at $1.00 each), and extension provisions (unlimited shareholder votes to extend, each with redemption rights). For investors tracking mechanics, the filing confirms the absence of a maximum redemption threshold and the sponsor's voting agreements. It also highlights potential conflicts: sponsor and officers may pursue other SPACs, and CFO Andrew Kucharchuk is involved with three other pre-business combination SPACs. No target has been selected.

Provides investors with all material terms of the SPAC IPO, including trust value per share ($10.00), deadline for business combination (24 months from closing), redemption rights, sponsor compensation (founder shares at $0.003 per share), dilution tables, conflicts of interest, and the fact that no target has been identified. This is the foundational disclosure for the SPAC's public offering.

What changed: A Schedule 13G beneficial ownership report filed on 2026-08-10 identifying Hudson Bay Capital Management LP and Sander Gerber as reporting holders. The provided filing excerpt discloses no share quantities, ownership percentages, acquisition dates, or cost bases. As a result, there is no alteration to the SPAC's redemption deadline (2028-04-30), the stated trust value per share ($10.06), deal progression, or sponsor conduct. Why it matters: Per SEC classification, a Schedule 13G indicates that Hudson Bay Capital Management LP and Sander Gerber collectively or individually beneficially own more than 5% of RREV's outstanding equity securities. For investors tracking redemption mechanics and capital deployment, this confirms the presence of external institutional and individual shareholders beyond the sponsor, but the excerpt's lack of quantitative metrics prevents assessment of their voting posture, potential support for a proposed business combination, or likelihood of driving redemption pressure. The document contains zero statements regarding customer contracts, revenue streams, market sizing, strategic initiatives, technology, partnerships, or litigation; it is strictly a regulatory ownership disclosure.

What changed: Quarterly Report on Form 10-Q of RRE Ventures Acquisition Corp. for the quarter ended March 31, 2026, including unaudited condensed financial statements and subsequent-event disclosures relating to its May 1, 2026 IPO and related-party arrangements. First periodic report after formation/IPO. It confirms RREV had no target selected and no substantive target discussions as of filing. The IPO closed May 1, 2026: 25,000,000 units at $10.00 per unit, with $250,000,000 placed in the trust account ($10.00 per Public Unit). The stated Combination Period is 24 months from the IPO closing. On May 14, 2026, underwriters forfeited the over-allotment option and the Sponsor surrendered/cancelled 1,250,000 Class B founder shares, leaving 8,333,333 Class B and 25,000,000 Class A outstanding. Sponsor still owed $1,970,000 of its $4,510,000 private-placement warrant purchase, recorded as a share subscription receivable; $289,501 of Sponsor loans remained outstanding. No extension terms were elected; the filing notes working capital loans could cover any future extension deposit. Why it matters: Confirms the operational baseline for redemption/wind-down tracking: $10.00 per-share trust value, a 24-month deadline running from the May 1, 2026 IPO close, and no announced deal progress. It also flags sponsor conduct and capital gaps: part of the Sponsor's warrant purchase price was unpaid at the balance-sheet date, and the Sponsor's indemnification capacity is limited because its only assets are company securities. The over-allotment forfeiture means no additional units were issued, leaving the trust at the base $250,000,000.

What changed: Form 4 — insider ownership report. Per the filer’s submission, RRE Sponsor, LLC (identified as the 10% owner) recorded zero non-derivative transactions and maintained unchanged holdings. This leaves the redemption deadline of 2028-04-30, the $10.06 trust/share value, extension timeline, target search progress, and sponsor conduct entirely unadjusted. The document contains no assertions, data, or forward-looking statements regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: For investors tracking redemption mechanics and sponsor behavior, this routine compliance exhibit establishes a verified custody baseline for the reporting period. Although it delivers no update to the SEARCHING designation or the $10.06 trust metric, continuous Form 4 surveillance remains critical to identifying abrupt sponsorship position shifts that historically precede pipeline announcements, bridge financing, or liquidation triggers ahead of the 2028-04-30 cutoff. Absent management commentary or amended registration statements, the filing functions solely as a transparency checkpoint rather than a catalyst.

What changed: A Form 8-K current report (Items 8.01 and 9.01) accompanied by Exhibit 99.1, a standard corporate press release. As detailed in the May 14, 2026 press release, holders of RRE Ventures Acquisition Corp.’s units may elect to separately trade the Class A ordinary shares (“RREV”) and redeemable warrants (“RREVW”) commencing May 20, 2026, while unsplit units continue under “RREVU.” Mechanically, the filing confirms the underwriters forfeited their over-allotment option on May 14, 2026, locking the total initial public offering at exactly 25,000,000 units purchased on May 1, 2026. This finalizes the capital table, preserves the existing trust balance per share, and leaves the shareholder redemption window and business combination deadline unaffected. Separately, the press release attributes a strategic focus to management for pursuing targets in technology, defense and space, robotics, quantum computing, professional sports, AI, energy, power, and other transformative sectors. Chief Executive Officer Philip Kassin signed the report on May 14, 2026. Why it matters: The transition to separate trading splits the unit premium between the equity and derivative legs, typically increasing volatility and establishing independent pricing rails for both RREV and RREVW ahead of any potential merger announcements. The explicit forfeiture of the over-allotment option eliminates any residual dilution risk from the IPO lockup and definitively closes the primary fundraising phase, allowing investors to calculate exact pro forma redemption thresholds and sponsor promote calculations based solely on the 25,000,000-unit baseline.

What changed: A Form 8-K current report and accompanying audited financial statement (Exhibit 99.1) that formally documents the consummation of an initial public offering and a concurrent private placement transaction. According to the registrant's Form 8-K Item 8.01 disclosure, the company completed its initial public offering of 25,000,000 units at $10.00 per unit on May 1, 2026, directing $250,000,000 ($10.00 per unit) into a U.S.-located trust account overseen by Continental Stock Transfer & Trust Company. The filing states that simultaneously, the company closed a private placement of 4,510,000 warrants to the sponsor and 2,500,000 warrants to Cohen and Company Capital Markets and Clear Street LLC for $1.00 per warrant, yielding $7,010,000 in gross proceeds; however, the audit exhibit notes that $1,970,000 of the sponsor’s purchase price remains undeposited and is recorded as a share subscription receivable. The sponsor’s related-party promissory note shows $289,501 outstanding as of the balance sheet date. The company carries a $10,000,000 deferred underwriting liability, which the underwriters have agreed to forfeit if a business combination fails to occur within 24 months. Public shareholders retain a redemption right tied to the trust account initially valued at $10.00 per public share plus accrued interest net of taxes, with the prospectus explicitly stating that deferred underwriting commissions will not reduce the per-share redemption price. An unexercised 45-day over-allotment option for up to 3,750,000 additional units remains open following the May 1, 2026 closing. Why it matters: As confirmed by the trust account reconciliation in the financial notes, the initial $250,000,000 cash balance establishes a baseline $10.00 per-share redemption floor, though permissible tax withdrawals from interest earnings will mechanically adjust that per-share value over the 24-month Combination Period leading to an approximate April 2028 liquidation deadline. If liquidation occurs, the notes specify that warrants will expire worthless and 9,583,333 founder shares (of which up to 1,250,000 remain subject to forfeiture based on over-allotment exercise) will be surrendered. The sponsor’s unpaid $1,970,000 receivable and $289,501 loan outstanding signal pre-combination working capital vulnerabilities that may trigger up to $1,500,000 in additional working capital loans, which management confirms are optionally convertible into private placement warrants at $1.00 each. Executive compensation frameworks outlined in the notes mandate a $7,500 monthly retainer and a $200-per-hour billing rate paid to Kujo Capital via Andrew Kucharchuk for finance, accounting, treasury, and SEC-reporting functions, alongside a binding promise of 25,000 founder shares upon business combination consummation. Management retains broad discretionary authority over the $250,000,000 net proceeds, though the filing conditions any initial business combination on targeting an aggregate fair market value equal to at least 80% of trust net assets (excluding deferred commissions and interest taxes). Anti-dilution provisions embedded in the warrant terms permit exercise price adjustments to $11.50 per share or lower if bridge financing drops below $9.20 per share during deal execution. The registrant explicitly states that no operating revenues have commenced, no acquisition targets have been identified, and all activities from February 26, 2026 through May 1, 2026 relate solely to organizational formation, $15,946,423 in offering costs, and trust funding logistics.

What changed: A routine compliance exhibit — a Form 4, which is an SEC insider ownership report. This document confirms that director Robert Scott Mancini executed no non-derivative transactions and holds no reported changes in holdings. Bearing on the tracked mechanics, the filing establishes zero insider trading activity that would signal sentiment shifts ahead of any extension vote or redemption window, indicates no alterations to sponsor conduct, and carries no immediate weight on trust value preservation or business combination pacing. Why it matters: Although the filing contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, it delivers operational clarity for investors monitoring a searching-phase SPAC. The explicit regulatory certification that no positions moved provides a verified baseline for assessing director alignment without resorting to speculation. All stated conditions are sourced directly from the standard disclosure template submitted by the issuer and its reporting officer.

What changed: SEC Form 4 insider ownership report. Director Brian Frederick Daly disclosed no non-derivative transactions or holdings adjustments for the covered period. Consequently, there are no alterations to the redemption schedule, trust per-share balance, business combination deadline, active SEARCHING mandate, or director trading posture. Why it matters: The submission functions as a procedural clearance rather than a strategic catalyst. It confirms that a named officer executed zero securities purchases, sales, or derivative exercises during the reporting window, leaving the SPAC’s search phase unmodified and providing no data on target pipeline development, trust account accrual, extension triggers, or sponsor alignment. Investors tracking liquidity events or corporate governance shifts will find no actionable signals in this filing.

What changed: A routine compliance exhibit — specifically, a Form 4 insider ownership report filed with the SEC. Per the reporting person Jeffrey Douglas Epstein (director, President), zero non-derivative transactions or holdings changes occurred. No shares were purchased, sold, converted, or exercised during the reporting period. Why it matters: The filing bears no direct impact on redemption deadline mechanics, trust value calculations, extension procedures, or target acquisition timelines. Because the document contains no figures, partnership announcements, customer metrics, or strategic disclosures, it offers no substantive signal regarding sponsor conviction, deal progress, or corporate conduct beyond confirming a static insider position. For calendar watchers, this entry registers as a null action that neither accelerates nor delays the business combination window.

What changed: This document IS a Form 4 insider ownership report. In its own regulatory terms, it is a routine compliance exhibit filed pursuant to Section 16(a) to disclose changes in beneficial ownership of common securities, specifically for reporting person Bernstein Bruce, director, at RRE Ventures Acquisition Corp. Nothing changed mechanically. The filing explicitly states "No non-derivative transactions or holdings reported." As a result, there are no updates to insider share counts, director purchasing or selling activity, or sponsor-related equity movements. Because the form records zero acquisitions or disposals, it does not alter the capital structure, does not impact the redemption threshold, and does not generate any new extension votes, termination clocks, or business combination milestones tied to insider block transfers. Why it matters: Beyond the mechanics, the document contains no substantive operational disclosures. There are no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel shifts sourced from executives or the issuer. All statements originate solely from Bernstein Bruce in his capacity as the named reporting person confirming a static post-transaction position. For investors tracking the redemption calendar and sponsor conduct, this zero-activity Form 4 serves as a verification baseline: it confirms no hidden accumulation or distribution by management that could otherwise influence redemption expectations or dilute the trust pool ahead of the prospectus deadline. It is a confirmatory administrative filing rather than a catalyst, leaving combination negotiations, voting proxies, and liquidity parameters untouched by this specific disclosure.

What changed: Form 4 insider ownership report. The exhibit records zero non-derivative transactions or holdings for Director and Chief Executive Officer Philip (Phil) Kassin. There are no modifications to insider equity positions, nor any submissions addressing the fund’s redemption timeline, trust accounting mechanics, extension approvals, business combination status, or sponsor governance actions. Why it matters: For participants monitoring the stated redemption cutoff and per-share trust balance, the blank Form 4 confirms the CEO executed neither purchases nor sales during the reporting window. This absence of insider trading activity provides no directional signal regarding liquidity stress or strategic conviction, while simultaneously confirming no deviation from standard disclosure windows. The document contains no further material regarding customer bases, revenue streams, addressable markets, technological platforms, commercial alliances, legal disputes, or management roster changes; it is limited to the standard issuance identification and reporting person declaration.